
|Articles|August 6, 2015
Canadian CRO Acquires CRO in India
Advertisement
JSS Medical Research, a Montreal-based CRO, recently concluded the acquisition of Max Neeman International, with head office in New Delhi, India. Additional regional offices are located in Ahmedabad, Bangalore, Chennai and Mumbai. Through a US subsidiary, a regional office is also located North Carolina.
This global expansion in India follows JSS’ acquisition of Latam Clinical Trials, a CRO in Bogota, Colombia that established the company’s presence in Latin America.
Read the full
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
2
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
3
Breaking the Efficacy Ceiling in IBD and Beyond
4
ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma
5




